Biotech entity
pharma is the sole category represented across all 1 tracked stories. David Perlmutter is most often covered alongside Aspen Ideas Festival, which appears in 1 of these 1 story. The tracked stories average 13 original sources each. David Perlmutter appears in 1 tracked Biotech story from July 12, 2026.
Last mentioned: Jul 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. David Perlmutter is most often covered alongside Aspen Ideas Festival, which appears in 1 of these 1 story. The tracked stories average 13 original sources each. David Perlmutter appears in 1 tracked Biotech story from July 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering David Perlmutter. Shared-story counts are live from our verified record — not editorial picks.
The transient global amnesia episode experienced by Katie Couric spotlights a rare condition with no targeted therapy, exposing a gap in CNS drug pipelines. The condition’s links to migraines and stress suggest repurposing opportunities, but market size and clinical trial hurdles remain obstacles.
David Perlmutter is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
